Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Changes in hospital adverse events and patient outcomes associated with private equity acquisition.

Kannan S, Bruch JD, Song Z. Changes in hospital adverse events and patient outcomes associated with private equity acquisition. JAMA. 2023;330(24):2365-2375. doi:10.1001/jama.2023.23147.

Save
Print
January 10, 2024
Kannan S, Bruch JD, Song Z. JAMA. 2023;330(24):2365-2375.
View more articles from the same authors.

Changes in hospital leadership and ownership can impact patient safety and health outcomes. This study compared hospital-acquired adverse events among Medicare patients treated at private equity-acquired hospitals versus matched controls over a ten-year period. Researchers found that Medicare patients experienced a 25% increase in hospital-acquired conditions when treated at private equity hospitals. Findings indicate a significant increase in in-hospital falls and healthcare-associated infections (i.e., central-line associated blood stream infections, surgical site infections) despite private equity hospitals placing fewer central lines overall and having lower surgical volume. There was no change in 30-day mortality after hospital discharge, but in-hospital mortality decreased slightly at private equity versus control hospitals.

Save
Print
Cite
Citation

Kannan S, Bruch JD, Song Z. Changes in hospital adverse events and patient outcomes associated with private equity acquisition. JAMA. 2023;330(24):2365-2375. doi:10.1001/jama.2023.23147.